Medpace (MEDP)
(Delayed Data from NSDQ)
$319.56 USD
+5.34 (1.70%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $319.71 +0.15 (0.05%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$319.56 USD
+5.34 (1.70%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $319.71 +0.15 (0.05%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
Zacks News
4 Momentum Stocks to Pick Despite MedTech Policy Debacle
by Zacks Equity Research
Investors might pay heed to Zacks counsel and hitch the momentum ride to tide over the Obamacare debacle.
Teladoc (TDOC) Looks Good: Stock Adds 6.8% in Session
by Zacks Equity Research
Teladoc (TDOC) was a big mover last session, as the company saw its shares rise nearly 7% on the day amid huge volumes.
HCA Healthcare Rides on Acquisitions, Weak Volumes Bother
by Zacks Equity Research
A number of acquisitions have added facilities and widened network at HCA Healthcare (HCA). Weak admissions, however, continue to bother.
Healthcare Q2 Earnings Set to Release on Jul 31: HLS, MEDP
by Zacks Equity Research
The Healthcare sector's earnings will be driven by continued efforts by the players to provide high-quality, cost-effective care, partly offset by rising medical and operating costs.
What Falling Estimates & Price Mean for Medpace Holdings (MEDP)
by Zacks Equity Research
Medpace Holdings, Inc. (MEDP) has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter and the current year.
Healthcare Q1 Earnings to Watch on May 1: THC, MEDP, CYH
by Zacks Equity Research
So far, 33.3% of the total Medical sector companies have reported first-quarter results.